Back

The efficacy and safety of hydroxychloroquine in patients with chronic inflammatory cardiomyopathy after fulminant myocarditis: a multicenter randomized study of the HYPIC trial

31 August 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Multidisciplinary care in heart failure Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Wu He

Tongji Hospital- Tongji Medical College, Wuhan (China)

6 More presentations in this session

Presentation thumbnail
Impact of QRS duration on drug titration and left ventricular recovery in new-onset heart failure with reduced ejection fraction
Doctor A. Arenas Loriente (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
A decision algorithm for palliative care initiation in heart failure patients
Doctor I. Santos (Ponta Delgada, PT)
Abstract Slides Video
Presentation thumbnail
Effects of a dyadic empowerment-based heart failure management program (De-HF) on patient-reported and clinical outcomes: a double-blind randomized controlled trial
Doctor D. Yu (Hong Kong, HK)
Abstract Slides Video
Presentation thumbnail
Efficacy of early initiation of vericiguat in acute heart failure: a prospective study
Doctor J. Chen (Chongqing, CN)
Abstract Slides Video
Presentation thumbnail
Vutrisiran reduces days lost to death and/or hospitalization versus placebo in patients with transthyretin amyloidosis with cardiomyopathy in the HELIOS-B trial
Doctor M. Hanna (Cleveland, US)
Abstract Slides Video

Access the full session

Session thumbnail
Multidisciplinary care in heart failure

The Event

Event poster

ESC Congress 2025

31 August 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Hydroxychloroquine cures autoimmune myocarditis by inhibiting innate immune via the CXCL16-CXCR6 axis between macrophages and T cells
thumbnail
Congress Presentation
Long-term hydroxychloroquine exposure impairs the left ventricular longitudinal strain
thumbnail
Congress Presentation
Sinomenine hydrochloride alleviates autoimmune myocarditis via suppressing Th1 cell induced-M1 macrophage pyroptosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources